Department of Medicine and Division of Infectious Diseases, David Geffen School of Medicine at the University of California, Los Angeles, California, US.
Partners in Hope, Lilongwe, MW.
Glob Heart. 2021 Dec 6;16(1):81. doi: 10.5334/gh.1081. eCollection 2021.
Hypertension is among the most commonly diagnosed non-communicable diseases in Africa, and studies have demonstrated a high prevalence of hypertension among individuals with HIV. Despite high prevalence, there has been limited attention on the clinical outcomes of hypertension treatment in this population.
We sought to characterize rates of and factors associated with blood pressure control over one year among individuals on antiretroviral therapy (ART) and antihypertensive medications.
We performed a prospective observational cohort study at an HIV clinic in Malawi. We defined uncontrolled hypertension as a systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg at two or more follow-up visits during the year, while controlled hypertension was defined as <140 mm Hg systolic and <90 mm Hg diastolic at all visits, or at all but one visit. We calculated an antihypertensive non-adherence score based on self-report of missed doses at each visit (higher score = worse adherence) and used rank sum and chi-square tests to compare sociodemographic and clinical factors (including adherence) associated with blood pressure control over the year.
At study entry, 158 participants (23.5%) were on antihypertensive medication; participants had a median age of 51.0 years, were 66.5% female, and had a median of 6.9 years on ART. 19.0% (n = 30) achieved blood pressure control over the year of follow-up. Self-reported non-adherence to hypertension medications was the only factor significantly associated with uncontrolled blood pressure. The average non-adherence score for those with controlled blood pressure was 0.22, and for those with uncontrolled blood pressure was 0.61 (p = 0.009).
Adults living with HIV and hypertension in our cohort had low rates of blood pressure control over one year associated with self-reported non-adherence to antihypertensive medications. Given the high prevalence and incidence of hypertension, interventions to improve blood pressure control are needed to prevent associated long-term cardio- and cerebrovascular morbidity and mortality.
高血压是非洲最常见的非传染性疾病之一,研究表明,HIV 感染者中高血压的患病率很高。尽管患病率很高,但针对该人群高血压治疗的临床结局,关注仍很有限。
我们旨在描述在接受抗逆转录病毒治疗(ART)和抗高血压药物治疗的个体中,一年内血压控制的比率和相关因素。
我们在马拉维的一家 HIV 诊所进行了一项前瞻性观察性队列研究。我们将未控制的高血压定义为在一年内两次或以上随访时收缩压≥140mmHg 和/或舒张压≥90mmHg,而控制的高血压定义为所有就诊时收缩压<140mmHg 和舒张压<90mmHg,或除一次就诊外所有就诊时均如此。我们根据每次就诊时漏服的次数(分数越高表示依从性越差)计算出抗高血压药物不依从性评分,并使用秩和检验和卡方检验比较了与一年内血压控制相关的社会人口学和临床因素(包括依从性)。
在研究开始时,158 名参与者(23.5%)正在服用抗高血压药物;参与者的中位年龄为 51.0 岁,66.5%为女性,ART 治疗中位时间为 6.9 年。19.0%(n=30)在随访的一年内达到了血压控制。抗高血压药物治疗的自我报告不依从是与未控制血压唯一显著相关的因素。血压控制良好者的平均不依从评分是 0.22,血压控制不佳者的平均不依从评分是 0.61(p=0.009)。
在我们的队列中,患有 HIV 和高血压的成年人在一年内血压控制率较低,这与抗高血压药物治疗的自我报告不依从有关。鉴于高血压的高患病率和发病率,需要采取干预措施来改善血压控制,以预防相关的长期心血管和脑血管发病率和死亡率。